proxyvotesnow.com

Home › Companies › HEALTH CATALYST INC. › 2023-2024

HEALTH CATALYST INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and HEALTH CATALYST INC.’s Form 8-K, filed 2024-06-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 6Reported items
  • 188Asset managers
  • 1,248Fund votes
  • 2024-06-13Meeting date

Proxy season: 2023-2024 2025-2026

Explore HEALTH CATALYST INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by HEALTH CATALYST INC.

These tallies are HEALTH CATALYST INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

HEALTH CATALYST INC. — official shareholder meeting results, meeting held 2024-06-13
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Daniel Burton 31,119,449---- 12,090,3335,967,527 Majority: yes
Elect Director: John A. Kane 30,312,852---- 12,896,9305,967,527 Majority: yes
Elect Director: Julie Larson-Green 30,723,384---- 12,486,3985,967,527 Majority: yes
Proposal 2: Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company's consolidated financial statements for the 49,068,137106,6622,510 ---- Majority: yes
Proposal 3: Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company's named executive officers 42,599,851597,26212,669 --5,967,527 Majority: yes

Source: HEALTH CATALYST INC., Form 8-K, filed with the SEC on 2024-06-17 — read the filing on EDGAR.

How asset managers voted at the HEALTH CATALYST INC. 2023-2024 meeting

Each item below shows how the 188 asset managers that disclosed a HEALTH CATALYST INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of HEALTH CATALYST INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory, non- binding basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 42,599,851AGAINST: 597,262

HEALTH CATALYST INC.’s own tally for this item (“Proposal 3: Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company's named”): 42,599,851 for, 597,262 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,956,132 outstanding shares: 72% for, 1% against (73% of the company cast a for/against vote).

The 188 asset managers below cast 99.2% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 99.2%
FOR: 99.2%AGAINST: 0.8%
Largest asset managers voting on “To approve, on an advisory, non- binding basis, the compensation of our named executive officers.” at HEALTH CATALYST INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock4,892,9640 00For
Vanguard4,471,2760 00For
PRIMECAP MANAGEMENT CO/CA/2,521,5440 00For
PRIMECAP Odyssey Funds2,234,2060 00For
Newton Investment Management North America, LLC2,174,5440 00For
Daventry Group, LP2,162,8750 00For
IMPAX FUNDS SERIES TRUST I2,154,4750 00For
Point721,759,4430 00For
Dimensional1,580,4870 00For
Fidelity1,452,3650 00For
Wellington1,428,2230 00For
JPMorgan1,371,3220 00For
GEODE CAPITAL MANAGEMENT, LLC1,319,4590 00For
KENNEDY CAPITAL MANAGEMENT LLC1,208,9900 00For
State Street1,164,8750 00For
BNY Mellon1,154,0880 00For
Goldman Sachs1,081,4110 00For
Charles Schwab1,022,0220 00For
Granahan Investment Management, LLC925,8250 00For
Alyeska Investment Group, L.P.807,0950 00For
Nuveen766,7090 00For
TIAA709,5890 00For
First Light Asset Management, LLC673,5200 00For
NOMURA ASSET MANAGEMENT CO LTD607,6360 00For
AMERICAN BEACON FUNDS454,5420 00For

Showing the 25 largest of 188 asset managers. See all 188 in the interactive database.

2. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF HEALTH CATALYST, INC. FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 49,068,137AGAINST: 106,662

HEALTH CATALYST INC.’s own tally for this item (“Proposal 2: Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company's co”): 49,068,137 for, 106,662 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,956,132 outstanding shares: 83% for, 0.2% against (83% of the company cast a for/against vote).

The 67 asset managers below cast 100% of the shares they voted on this item FOR (20,850,002 for, 0 against).

FOR 100%
FOR: 20,850,002 (100.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF H” at HEALTH CATALYST INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,180,4100 00For
BlackRock2,470,1460 00For
PRIMECAP Odyssey Funds2,234,2060 00For
IMPAX FUNDS SERIES TRUST I2,154,4750 00For
Dimensional1,374,3780 00For
Fidelity1,364,3520 00For
BNY Mellon1,154,0880 00For
TIAA709,5890 00For
JPMorgan624,3320 00For
Charles Schwab511,0110 00For
Goldman Sachs469,8720 00For
AMERICAN BEACON FUNDS454,5420 00For
Jackson National343,7210 00For
MFS291,2810 00For
Columbia Threadneedle220,2830 00For
Nationwide212,6160 00For
BBH Trust160,0000 00For
SEI151,7580 00For
Victory Capital149,5410 00For
Equitable138,2850 00For
Lincoln Financial133,6250 00For
QUANTITATIVE MASTER SERIES LLC106,4400 00For
Voya91,5070 00For
Prudential/PGIM75,6230 00For
EXCHANGE TRADED CONCEPTS TRUST74,2570 00For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

3. Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Daniel Burton

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%WITHHELD 28%
FOR: 31,119,449WITHHELD: 12,090,333

HEALTH CATALYST INC.’s own tally for this item (“Elect Director: Daniel Burton”): 31,119,449 for, 12,090,333 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,956,132 outstanding shares: 52.8% for, 21% withheld (73% of the company cast a for/withheld vote).

The 64 asset managers below cast 100% of the shares they voted on this item FOR (17,550,081 for, 0 against).

FOR 84%ABSTAIN 16%
FOR: 17,550,081 (84.4%)ABSTAIN: 3,240,055 (15.6%)
Largest asset managers voting on “Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholde” at HEALTH CATALYST INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,180,4100 00For
BlackRock2,470,1460 00For
PRIMECAP Odyssey Funds2,234,2060 00For
IMPAX FUNDS SERIES TRUST I2,154,4750 00For
Dimensional00 1,374,3780Abstain
Fidelity1,364,0540 2980For
BNY Mellon1,154,0880 00For
TIAA709,5890 00For
JPMorgan624,3320 00For
Charles Schwab511,0110 00For
Goldman Sachs00 469,8720Abstain
AMERICAN BEACON FUNDS454,5420 00For
Jackson National00 343,7210Abstain
MFS291,2810 00For
Columbia Threadneedle220,2830 00For
Nationwide00 212,6160Abstain
BBH Trust160,0000 00For
SEI151,7580 00For
Victory Capital00 149,5410Abstain
Equitable138,2850 00For
Lincoln Financial105,0310 28,5940For
QUANTITATIVE MASTER SERIES LLC106,4400 00For
Voya91,5070 00For
Prudential/PGIM00 75,6230Abstain
EXCHANGE TRADED CONCEPTS TRUST00 74,2570Abstain

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

4. Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: John A. Kane

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

70% Majority: yes · of votes cast

FOR 70%WITHHELD 30%
FOR: 30,312,852WITHHELD: 12,896,930

HEALTH CATALYST INC.’s own tally for this item (“Elect Director: John A. Kane”): 30,312,852 for, 12,896,930 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,956,132 outstanding shares: 51.4% for, 22% withheld (73% of the company cast a for/withheld vote).

The 64 asset managers below cast 100% of the shares they voted on this item FOR (17,119,373 for, 0 against).

FOR 82%ABSTAIN 18%
FOR: 17,119,373 (82.3%)ABSTAIN: 3,670,763 (17.7%)
Largest asset managers voting on “Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholde” at HEALTH CATALYST INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,180,4100 00For
BlackRock2,470,1460 00For
PRIMECAP Odyssey Funds2,234,2060 00For
IMPAX FUNDS SERIES TRUST I2,154,4750 00For
Dimensional00 1,374,3780Abstain
Fidelity1,364,0540 2980For
BNY Mellon1,154,0880 00For
TIAA709,5890 00For
JPMorgan624,3320 00For
Charles Schwab511,0110 00For
Goldman Sachs00 469,8720Abstain
AMERICAN BEACON FUNDS454,5420 00For
Jackson National00 343,7210Abstain
MFS00 291,2810Abstain
Columbia Threadneedle220,2830 00For
Nationwide00 212,6160Abstain
BBH Trust160,0000 00For
SEI151,7580 00For
Victory Capital00 149,5410Abstain
Equitable90,3650 47,9200For
Lincoln Financial105,0310 28,5940For
QUANTITATIVE MASTER SERIES LLC106,4400 00For
Voya00 91,5070Abstain
Prudential/PGIM00 75,6230Abstain
EXCHANGE TRADED CONCEPTS TRUST00 74,2570Abstain

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

5. Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Julie Larson-Green

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD 29%
FOR: 30,723,384WITHHELD: 12,486,398

HEALTH CATALYST INC.’s own tally for this item (“Elect Director: Julie Larson-Green”): 30,723,384 for, 12,486,398 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,956,132 outstanding shares: 52.1% for, 21% withheld (73% of the company cast a for/withheld vote).

The 64 asset managers below cast 100% of the shares they voted on this item FOR (17,210,880 for, 0 against).

FOR 83%ABSTAIN 17%
FOR: 17,210,880 (82.8%)ABSTAIN: 3,579,256 (17.2%)
Largest asset managers voting on “Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholde” at HEALTH CATALYST INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,180,4100 00For
BlackRock2,470,1460 00For
PRIMECAP Odyssey Funds2,234,2060 00For
IMPAX FUNDS SERIES TRUST I2,154,4750 00For
Dimensional00 1,374,3780Abstain
Fidelity1,364,0540 2980For
BNY Mellon1,154,0880 00For
TIAA709,5890 00For
JPMorgan624,3320 00For
Charles Schwab511,0110 00For
Goldman Sachs00 469,8720Abstain
AMERICAN BEACON FUNDS454,5420 00For
Jackson National00 343,7210Abstain
MFS00 291,2810Abstain
Columbia Threadneedle220,2830 00For
Nationwide00 212,6160Abstain
BBH Trust160,0000 00For
SEI151,7580 00For
Victory Capital00 149,5410Abstain
Equitable90,3650 47,9200For
Lincoln Financial105,0310 28,5940For
QUANTITATIVE MASTER SERIES LLC106,4400 00For
Voya91,5070 00For
Prudential/PGIM00 75,6230Abstain
EXCHANGE TRADED CONCEPTS TRUST00 74,2570Abstain

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

6. DIRECTOR

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (13,627 for, 0 against).

FOR: 13,627 (100.0%)
Largest asset managers voting on “DIRECTOR” at HEALTH CATALYST INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Zacks Trust9,6870 00For
SARATOGA ADVANTAGE TRUST3,9400 00For

Largest HEALTH CATALYST INC. shareholders voting in 2023-2024

Ranked by the number of HEALTH CATALYST INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 58,956,132 shares outstanding at the time of that meeting.

Top HEALTH CATALYST INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1BlackRock 8.30%
2Vanguard 7.58%
3PRIMECAP MANAGEMENT CO/CA/ 4.28%
4PRIMECAP Odyssey Funds 3.79%
5Newton Investment Management North America, LLC 3.69%
6Daventry Group, LP 3.67%
7IMPAX FUNDS SERIES TRUST I 3.65%
8Point72 2.98%
9Dimensional 2.68%
10Fidelity 2.46%

Reported HEALTH CATALYST INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

HEALTH CATALYST INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 9.33% 13F
S F 8.90% 13G
Vanguard Group 7.29% 13F
BNY Mellon 4.22% 13F
Point72 3.45% 13F
Dimensional Fund Advisors 2.76% 13F
State Street 2.24% 13F
Geode Capital 2.24% 13F
Millennium Management 2.08% 13F
JPMorgan Chase 1.38% 13F

Percentages above are of 58,956,132 shares outstanding, as reported by HEALTH CATALYST INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HEALTH CATALYST INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At HEALTH CATALYST INC.'s shareholder meeting held 2024-06-13, in the 2023-2024 proxy season, 188 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,248 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory, non- binding basis, the compensation of our named executive… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: HEALTH CATALYST INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-17.

HEALTH CATALYST INC. proxy season coverage: 2023-2024 (this page) · 2025-2026.